General
NMDOH Announces Start of Influenza (Flu) Season
Changes in New Mexico Illicit Opioid Supply
The New Mexico Department of Health (NMDOH) has identified an outbreak of Shigella flexneri occurring in Bernalillo County. Three out of four cases are experiencing homelessness. Tested samples have genomic patterns which confer resistance to floroquinolones, the class of antibiotics commonly used to treat Shigella infections.
Increase in Whooping Cough
On August 22, 2024, the FDA approved and granted emergency use authorization (EUA) to the 2024-2025 formulation of both the Moderna COVID-19 and the Pfizer-BioNTech COVID-19 vaccines for everyone 6 months of age and older. On August 30, the FDA granted EUA to the updated 2024-2025Novavax COVID-19 vaccine. The updated COVID vaccines were also endorsed by the Advisory Committee on Immunization Practices (ACIP) and the CDC.
Increase in Human Parvovirus B19 Activity in the United States
Confirmed Case of Acute Flaccid Myelitis (AFM)
Highly Pathogenic Influenza Testing Reminder
Two Cases of Measles Confirmed in Taos County
Xylazine Detected in NM Drug Supply
NMDOH Marks The End of The 2023 - 2024 Influenza Season
Highly Pathogenic Avian Influenza Identified in New-Mexico for Veterinerians
Highly Pathogenic Avian Influenza identified in New Mexico Cattle and Texas Resident
MPOX cases have declined in the United States since the peak of the outbreak in mid-August
On February 28, 2024, the Centers for Disease Control and Prevention (CDC) endorsed the Advisory Committee on Immunization Practices (ACIP) recommendation for adults aged 65 years and older to receive an additional dose of the updated 2023-2024 COVID-19 vaccine.
The New Mexico Department of Health (NMDOH) is notifying healthcare providers that there is an increasing incidence of measles in the United States and in other countries.
Healthcare providers in New Mexico can improve coverage with lifesaving vaccines and antivirals for influenza this season. Influenza vaccination coverage among adults ≥65 years old in New Mexico has increased between the previous two seasons, but at 63% this high-risk population remains below the full population Healthy People 2030 target of 70%.
Immunization Coverage for Influenza, COVID-19 and Use of Authorized/Approved Therapeutics
CDC Advisory - High Blood Lead Levels in Children Consuming Recalled Cinnamon
Protecting Infants from RSV during the National Nirsevimab (Beyfortus) Shortage